Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN HUFFAKER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1558824292
CMS profile
10420309
Location
VENICE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$20.89

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $20.89 1

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Eisai Inc. $20.89 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN HUFFAKER

NPI 1558824292 · CMS profile ID 10420309

Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family

VENICE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1558824292?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN HUFFAKER, NPI 1558824292, CMS profile ID 10420309. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1558824292?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JOHN HUFFAKER, NPI 1558824292, CMS profile ID 10420309. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1558824292?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JOHN HUFFAKER, NPI 1558824292, CMS profile ID 10420309, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1558824292?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $20.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Eisai Inc. $20.8912/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845776295 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $20.89 1
PY2023 $15.92 1
PY2024 $43.96 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,296,431.31 32
PY2024 Recipient $17,997.60 4
PY2024 Principal investigator $3,104,411.55 55
PY2023 Recipient $147.50 2
PY2023 Principal investigator $3,646,147.55 31

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

32 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $50.00 11/20/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213806054
Principal investigator 1 Novo Nordisk AS $4,047.57 10/29/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213795574
Principal investigator 1 Novo Nordisk AS $50.00 08/22/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213835540
Principal investigator 1 Novo Nordisk AS $75.00 08/22/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213835956
Principal investigator 1 Novo Nordisk AS $4,626.88 07/16/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213789640
Principal investigator 1 Vanda Pharmaceuticals Inc. $5,670.00 06/27/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945595
Principal investigator 1 Vanda Pharmaceuticals Inc. $3,780.00 06/27/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945599
Principal investigator 1 Novo Nordisk AS $225.00 06/23/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213822074
Principal investigator 1 Novo Nordisk AS $250.00 05/21/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213721116
Principal investigator 1 Eli Lilly and Company $31.92 05/16/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
A STUDY OF DIFFERENT DONANEMAB (LY3002813) DOSING REGIMENS IN ADULTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 6) No dispute reported 06/30/2026 1187884436
Principal investigator 1 Vanda Pharmaceuticals Inc. $250.00 05/09/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945380
Principal investigator 1 Vanda Pharmaceuticals Inc. $375.00 05/09/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945386
Principal investigator 1 Eli Lilly and Company $3,851.00 04/30/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
A RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MEVIDALEN IN PATIENTS WITH ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187880923
Principal investigator 1 Novo Nordisk AS $200.00 04/21/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213742009
Principal investigator 1 Novo Nordisk AS $823.08 04/21/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213745324
Principal investigator 1 Vanda Pharmaceuticals Inc. $3,072.00 04/21/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945151
Principal investigator 1 Vanda Pharmaceuticals Inc. $375.00 04/21/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232945155
Principal investigator 1 Novo Nordisk AS $1,945.00 02/21/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213742396
Principal investigator 1 Eli Lilly and Company $15,227.00 02/10/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3372689 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187882922
Principal investigator 1 Eli Lilly and Company $195.00 01/31/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
A RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MEVIDALEN IN PATIENTS WITH ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187886216
Principal investigator 1 Novo Nordisk AS $2,185.95 01/31/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC RESEARCH CENTER
NN6535-4725 No dispute reported 06/30/2026 1213711905
Principal investigator 1 Eli Lilly and Company $1,047.29 01/27/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187885666
Principal investigator 1 Eli Lilly and Company $4,692.35 01/27/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY MEASURED BY AMYLOID REDUCTION OF LY3372993 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187887384
Principal investigator 1 Vanda Pharmaceuticals Inc. $500.00 01/24/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944646
Principal investigator 1 Vanda Pharmaceuticals Inc. $9,216.00 01/24/2025 Non-covered Recipient Entity
ERG HOLDING COMPANY LLC
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness No dispute reported 06/30/2026 1232944650
Principal investigator 1 Eli Lilly and Company $13,940.62 01/23/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187885668
Principal investigator 1 Eli Lilly and Company $153,080.00 01/21/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY MEASURED BY AMYLOID REDUCTION OF LY3372993 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187879389
Principal investigator 1 Eli Lilly and Company $16,436.00 01/21/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187882020
Principal investigator 1 Eli Lilly and Company $29,446.00 01/15/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
A RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MEVIDALEN IN PATIENTS WITH ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187880603
Principal investigator 1 Eli Lilly and Company $1,483.65 01/09/2025 Non-covered Recipient Entity
NEUROPSYCHIATRIC ASSOCIATES OF SOUTHWEST FL PA
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3372689 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187884904
Principal investigator 1 Eli Lilly and Company $260,002.00 01/07/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187881498
Principal investigator 1 Eli Lilly and Company $759,282.00 01/07/2025 Non-covered Recipient Entity
ERG HOLDING CO LLC DBA ST LOUIS CLINICAL TRIALS LLC
A STUDY OF DIFFERENT DONANEMAB (LY3002813) DOSING REGIMENS IN ADULTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 6) No dispute reported 06/30/2026 1187882022